Literature DB >> 33484817

Triptolide delivery: Nanotechnology-based carrier systems to enhance efficacy and limit toxicity.

Qing Ren1, Meimei Li2, Yun Deng3, Aiping Lu4, Jun Lu5.   

Abstract

Triptolide (TP) possesses a wide range of biological and pharmacological activities involved in the treatment of various diseases. However, widespread usages of TP raise the urgent issues of the severe toxicity, which hugely limits its further clinical application. The novel functional nanostructured delivery system, which is of great significance in enhancing the efficacy, reducing side effects and improving bioavailability, could improve the enrichment, penetration and controlled release of drugs in the lesion location. Over the past decades, considerable efforts have been dedicated to designing and developing a variety of TP delivery systems with the intention of alleviating the adverse toxicity effects and enhancing the bioavailability. In this review, we briefly summarized and discussed the recent functionalized nano-TP delivery systems for the momentous purpose of guiding further development of novel TP delivery systems and providing perspectives for future clinical applications.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bioavailability; Nanostructured delivery system; Side effects; Triptolide

Mesh:

Substances:

Year:  2021        PMID: 33484817     DOI: 10.1016/j.phrs.2020.105377

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  6 in total

Review 1.  Recent advances of N-heterocyclic carbenes in the applications of constructing carbo- and heterocyclic frameworks with potential biological activity.

Authors:  Mei-Mei Li; Xiaozhen Chen; Yun Deng; Jun Lu
Journal:  RSC Adv       Date:  2021-11-26       Impact factor: 4.036

2.  γ-Cyclodextrin metal-organic framework as a carrier to deliver triptolide for the treatment of hepatocellular carcinoma.

Authors:  Zhe Li; Gang Yang; Rong Wang; Yuanyuan Wang; Jing Wang; Meng Yang; Chunai Gong; Yongfang Yuan
Journal:  Drug Deliv Transl Res       Date:  2021-04-15       Impact factor: 4.617

3.  Mechanochemical preparation of triptolide-loaded self-micelle solid dispersion with enhanced oral bioavailability and improved anti-tumor activity.

Authors:  Dabu Zhu; Qiuqin Zhang; Yifang Chen; Minghua Xie; Jianbo Li; Shen Yao; Ming Li; Zhao Lou; Yue Cai; Xuanrong Sun
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

4.  αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma.

Authors:  Yongwei Gu; Yue Du; Liangdi Jiang; Xiaomeng Tang; Aixue Li; Yunan Zhao; Yitian Lang; Xiaoyan Liu; Jiyong Liu
Journal:  J Nanobiotechnology       Date:  2022-08-23       Impact factor: 9.429

5.  Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis.

Authors:  Shujing Ren; Heng Liu; Xitong Wang; Jiquan Bi; Shengfeng Lu; Chenqi Zhu; Huizhu Li; Wenliang Kong; Rui Chen; Zhipeng Chen
Journal:  J Nanobiotechnology       Date:  2021-12-07       Impact factor: 10.435

6.  Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy.

Authors:  Yanwen Zheng; Fanhua Kong; Songyang Liu; Xi Liu; Dongni Pei; Xiongying Miao
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.